<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37328162</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>Cigarette smoking is associated with decreased long-term treatment cessation of mycophenolate mofetil and methotrexate in cutaneous lupus erythematosus.</ArticleTitle><Pagination><StartPage>1134</StartPage><EndPage>1137</EndPage><MedlinePgn>1134-1137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231183500</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Henry W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprow</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werth</LastName><ForeName>Victoria P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chong</LastName><ForeName>Benjamin F</ForeName><Initials>BF</Initials><Identifier Source="ORCID">0000-0002-4092-7658</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AR061441</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AR002207</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR071653</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>HU9DX48N0T</RegistryNumber><NameOfSubstance UI="D009173">Mycophenolic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>YL5FZ2Y5U1</RegistryNumber><NameOfSubstance UI="D008727">Methotrexate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009173" MajorTopicYN="N">Mycophenolic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008727" MajorTopicYN="N">Methotrexate</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073865" MajorTopicYN="Y">Cigarette Smoking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028761" MajorTopicYN="N">Withholding Treatment</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Chong is an investigator for Daavlin Corporation and Biogen Incorporated. He is a consultant for Bristol Meyers Squibb, EMD Serono, Horizon Therapeutics, Biogen Incorporated, and Amgen Incorporated. He receives royalties from MAPI Research Trust. Dr. Werth receives grants from Celgene, Amgen, Janssen, Biogen, Gilead, Viela, Horizon therapeutics, Ventus Therapeutics and consults for Astra-Zeneca, Pfizer, Biogen, Celgene, Resolve, Janssen, Gilead, Lilly, BMS, Nektar, Abbvie, Viela, GSK, EMD Serona, Sanofi, Anaptysbio, Amgen, Merck, Kyowa Kirin, and Rome Therapeutics. She receives royalties from MAPI Research Trust. The other authors have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328162</ArticleId><ArticleId IdType="mid">NIHMS1906897</ArticleId><ArticleId IdType="pmc">PMC10527208</ArticleId><ArticleId IdType="doi">10.1177/09612033231183500</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Kane D, McCourt C, Meggitt S, et al. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. Br J Dermatol 2021; 185: 1112&#x2013;1123. 2021/06/26. DOI: 10.1111/bjd.20597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.20597</ArticleId><ArticleId IdType="pubmed">34170012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonigo G, Jachiet M, Bessis D, et al. Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patients. J Am Acad Dermatol 2021. 2021/08/02. DOI: 10.1016/j.jaad.2021.07.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2021.07.038</ArticleId><ArticleId IdType="pubmed">34333080</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyes E, Jobanputra A, Feng R, et al. Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study. J Am Acad Dermatol 2021. 2021/09/20. DOI: 10.1016/j.jaad.2021.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2021.09.017</ArticleId><ArticleId IdType="pmc">PMC10233728</ArticleId><ArticleId IdType="pubmed">34537250</ArticleId></ArticleIdList></Reference><Reference><Citation>Florez-Pollack S, Rizvi SK, Hynan LS, et al. Discoid lesions and smoking history are negative predictors of disease activity remission in cutaneous lupus erythematosus. J Am Acad Dermatol 2022. 2022/02/14. DOI: 10.1016/j.jaad.2022.01.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2022.01.052</ArticleId><ArticleId IdType="pmc">PMC9365882</ArticleId><ArticleId IdType="pubmed">35151758</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Frances C, Barete S, et al. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature. J Am Acad Dermatol 2015; 72: 634&#x2013;639. 2015/02/05. DOI: 10.1016/j.jaad.2014.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2014.12.025</ArticleId><ArticleId IdType="pubmed">25648824</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris A, Perra D, Cangemi I, et al. Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naive to DMARDs: Results from a retrospective cohort study. Medicine (Baltimore) 2021; 100: e25481. 2021/04/29. DOI: 10.1097/MD.0000000000025481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025481</ArticleId><ArticleId IdType="pmc">PMC8084001</ArticleId><ArticleId IdType="pubmed">33907096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels CM, Johnson L, Ramly E, et al. Impact of a Rheumatology Clinic Protocol on Tobacco Cessation Quit Line Referrals. Arthritis Care Res (Hoboken) 2022; 74: 1421&#x2013;1429. 2021/04/08. DOI: 10.1002/acr.24589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24589</ArticleId><ArticleId IdType="pmc">PMC8492788</ArticleId><ArticleId IdType="pubmed">33825349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Olivo MA, Sharma G, Singh G, et al. A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis. PLoS One 2022; 17: e0279065. 2022/12/16. DOI: 10.1371/journal.pone.0279065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0279065</ArticleId><ArticleId IdType="pmc">PMC9754184</ArticleId><ArticleId IdType="pubmed">36520847</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>